Client First Investment Management LLC Sells 39,368 Shares of ARK Genomic Revolution ETF $ARKG

Client First Investment Management LLC decreased its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 64.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,953 shares of the company’s stock after selling 39,368 shares during the quarter. ARK Genomic Revolution ETF comprises approximately 0.6% of Client First Investment Management LLC’s holdings, making the stock its 20th largest position. Client First Investment Management LLC’s holdings in ARK Genomic Revolution ETF were worth $1,190,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. NewEdge Advisors LLC boosted its position in shares of ARK Genomic Revolution ETF by 102.6% in the first quarter. NewEdge Advisors LLC now owns 24,092 shares of the company’s stock valued at $637,000 after acquiring an additional 12,202 shares during the period. Nwam LLC raised its stake in ARK Genomic Revolution ETF by 55.3% during the 2nd quarter. Nwam LLC now owns 31,704 shares of the company’s stock valued at $1,333,000 after purchasing an additional 11,294 shares during the last quarter. Group One Trading LLC boosted its holdings in ARK Genomic Revolution ETF by 168.3% in the 1st quarter. Group One Trading LLC now owns 45,861 shares of the company’s stock valued at $1,212,000 after purchasing an additional 28,765 shares during the period. Gateway Wealth Partners LLC acquired a new stake in ARK Genomic Revolution ETF in the 1st quarter worth $349,000. Finally, Moran Wealth Management LLC grew its position in ARK Genomic Revolution ETF by 79.6% in the 1st quarter. Moran Wealth Management LLC now owns 49,204 shares of the company’s stock worth $1,300,000 after purchasing an additional 21,811 shares during the last quarter.

ARK Genomic Revolution ETF Stock Performance

BATS:ARKG opened at $51.30 on Friday. The firm’s 50-day moving average is $48.13 and its 200-day moving average is $38.64. ARK Genomic Revolution ETF has a 52-week low of $24.60 and a 52-week high of $58.83.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.